
Roy R. Teller
Examiner (ID: 12058, Phone: (571)272-0971 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675, 1653 |
| Total Applications | 671 |
| Issued Applications | 374 |
| Pending Applications | 45 |
| Abandoned Applications | 251 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5296001
[patent_doc_number] => 20090010927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells'
[patent_app_type] => utility
[patent_app_number] => 11/789239
[patent_app_country] => US
[patent_app_date] => 2007-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 80575
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20090010927.pdf
[firstpage_image] =>[orig_patent_app_number] => 11789239
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/789239 | Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells | Apr 23, 2007 | Issued |
Array
(
[id] => 4287
[patent_doc_number] => 07816326
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-19
[patent_title] => 'Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease'
[patent_app_type] => utility
[patent_app_number] => 11/733479
[patent_app_country] => US
[patent_app_date] => 2007-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9455
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/816/07816326.pdf
[firstpage_image] =>[orig_patent_app_number] => 11733479
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/733479 | Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease | Apr 9, 2007 | Issued |
Array
(
[id] => 5558009
[patent_doc_number] => 20090269586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'Multimicrolamellar Collagen Membranes'
[patent_app_type] => utility
[patent_app_number] => 12/296018
[patent_app_country] => US
[patent_app_date] => 2007-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14131
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20090269586.pdf
[firstpage_image] =>[orig_patent_app_number] => 12296018
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/296018 | Multimicrolamellar Collagen Membranes | Apr 2, 2007 | Abandoned |
Array
(
[id] => 4734366
[patent_doc_number] => 20080051346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'Compounds and methods for modulating cell-adhesion mediated drug resistance'
[patent_app_type] => utility
[patent_app_number] => 11/731947
[patent_app_country] => US
[patent_app_date] => 2007-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 16787
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20080051346.pdf
[firstpage_image] =>[orig_patent_app_number] => 11731947
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/731947 | Compounds and methods for modulating cell-adhesion mediated drug resistance | Mar 29, 2007 | Abandoned |
Array
(
[id] => 8435546
[patent_doc_number] => 08283315
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-09
[patent_title] => 'Inhibition of tumour growth'
[patent_app_type] => utility
[patent_app_number] => 11/726172
[patent_app_country] => US
[patent_app_date] => 2007-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 31060
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11726172
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/726172 | Inhibition of tumour growth | Mar 20, 2007 | Issued |
Array
(
[id] => 4977893
[patent_doc_number] => 20070219126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Class of bioactive glycoprotein'
[patent_app_type] => utility
[patent_app_number] => 11/711141
[patent_app_country] => US
[patent_app_date] => 2007-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10826
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20070219126.pdf
[firstpage_image] =>[orig_patent_app_number] => 11711141
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/711141 | Class of bioactive glycoprotein | Feb 26, 2007 | Abandoned |
Array
(
[id] => 5091676
[patent_doc_number] => 20070231315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Stabilized preparations of serine endopeptidases, their preparation and use'
[patent_app_type] => utility
[patent_app_number] => 11/709747
[patent_app_country] => US
[patent_app_date] => 2007-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8776
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0231/20070231315.pdf
[firstpage_image] =>[orig_patent_app_number] => 11709747
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/709747 | Stabilized preparations of serine endopeptidases, their preparation and use | Feb 22, 2007 | Issued |
Array
(
[id] => 162543
[patent_doc_number] => 07671025
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-02
[patent_title] => 'Neurotensin receptor agonists and opioid receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 11/709991
[patent_app_country] => US
[patent_app_date] => 2007-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8735
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/671/07671025.pdf
[firstpage_image] =>[orig_patent_app_number] => 11709991
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/709991 | Neurotensin receptor agonists and opioid receptor agonists | Feb 22, 2007 | Issued |
Array
(
[id] => 6000534
[patent_doc_number] => 20110117017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'PEPTIDES WITH PROPERTIES OF AN ALLOSTERIC ANTAGONIST SELECTIVE FOR THE ALPHA 1A ADRENERGIC RECEPTOR AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/279250
[patent_app_country] => US
[patent_app_date] => 2007-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7028
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117017.pdf
[firstpage_image] =>[orig_patent_app_number] => 12279250
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/279250 | PEPTIDES WITH PROPERTIES OF AN ALLOSTERIC ANTAGONIST SELECTIVE FOR THE ALPHA 1A ADRENERGIC RECEPTOR AND USES THEREOF | Feb 22, 2007 | Abandoned |
Array
(
[id] => 6552686
[patent_doc_number] => 20100233302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'THE USE OF A VEGF BINDING PEPTIDE TO RETARD HAIR GROWTH'
[patent_app_type] => utility
[patent_app_number] => 12/160475
[patent_app_country] => US
[patent_app_date] => 2007-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5010
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20100233302.pdf
[firstpage_image] =>[orig_patent_app_number] => 12160475
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/160475 | THE USE OF A VEGF BINDING PEPTIDE TO RETARD HAIR GROWTH | Jan 25, 2007 | Abandoned |
Array
(
[id] => 5538817
[patent_doc_number] => 20090220622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'USE OF MIMOSINE OR A DERIVATIVE THEREOF FOR TREATING THE CUTANEOUS EFFECTS OF PSORIASIS AND RELATED SKIN DISORDERS, AND COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/161924
[patent_app_country] => US
[patent_app_date] => 2007-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11102
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220622.pdf
[firstpage_image] =>[orig_patent_app_number] => 12161924
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/161924 | USE OF MIMOSINE OR A DERIVATIVE THEREOF FOR TREATING THE CUTANEOUS EFFECTS OF PSORIASIS AND RELATED SKIN DISORDERS, AND COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING SAME | Jan 22, 2007 | Abandoned |
Array
(
[id] => 54042
[patent_doc_number] => 07767649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-03
[patent_title] => 'Amino acid conjugates providing for sustained systemic concentrations of GABA analogues'
[patent_app_type] => utility
[patent_app_number] => 11/654598
[patent_app_country] => US
[patent_app_date] => 2007-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18049
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/767/07767649.pdf
[firstpage_image] =>[orig_patent_app_number] => 11654598
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/654598 | Amino acid conjugates providing for sustained systemic concentrations of GABA analogues | Jan 17, 2007 | Issued |
Array
(
[id] => 1077022
[patent_doc_number] => 07615535
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-10
[patent_title] => 'Inhibiting GS-FDH to modulate no bioactivity'
[patent_app_type] => utility
[patent_app_number] => 11/648406
[patent_app_country] => US
[patent_app_date] => 2006-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9493
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/615/07615535.pdf
[firstpage_image] =>[orig_patent_app_number] => 11648406
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/648406 | Inhibiting GS-FDH to modulate no bioactivity | Dec 28, 2006 | Issued |
Array
(
[id] => 5005495
[patent_doc_number] => 20070203066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Compositions and methods for inhibiting cellular proliferation'
[patent_app_type] => utility
[patent_app_number] => 11/636353
[patent_app_country] => US
[patent_app_date] => 2006-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17740
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20070203066.pdf
[firstpage_image] =>[orig_patent_app_number] => 11636353
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/636353 | Compositions and methods for inhibiting cellular proliferation | Dec 7, 2006 | Abandoned |
Array
(
[id] => 5005495
[patent_doc_number] => 20070203066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Compositions and methods for inhibiting cellular proliferation'
[patent_app_type] => utility
[patent_app_number] => 11/636353
[patent_app_country] => US
[patent_app_date] => 2006-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17740
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20070203066.pdf
[firstpage_image] =>[orig_patent_app_number] => 11636353
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/636353 | Compositions and Methods for Inhibiting Cellular Proliferation | Dec 7, 2006 | Abandoned |
Array
(
[id] => 5125547
[patent_doc_number] => 20070237818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Controlled-release formulation of HCV protease inhibitor and methods using the same'
[patent_app_type] => utility
[patent_app_number] => 11/636701
[patent_app_country] => US
[patent_app_date] => 2006-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 50451
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20070237818.pdf
[firstpage_image] =>[orig_patent_app_number] => 11636701
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/636701 | Controlled-release formulation of HCV protease inhibitor and methods using the same | Dec 6, 2006 | Abandoned |
Array
(
[id] => 6646090
[patent_doc_number] => 20100228005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-09
[patent_title] => 'Process for the Purification of Macrolide Antibiotics'
[patent_app_type] => utility
[patent_app_number] => 12/095642
[patent_app_country] => US
[patent_app_date] => 2006-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 984
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20100228005.pdf
[firstpage_image] =>[orig_patent_app_number] => 12095642
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/095642 | Process for the purification of macrolide antibiotics | Dec 6, 2006 | Issued |
Array
(
[id] => 5131552
[patent_doc_number] => 20070207949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'Medicaments and methods combining a HCV protease inhibitor and an AKR competitor'
[patent_app_type] => utility
[patent_app_number] => 11/635470
[patent_app_country] => US
[patent_app_date] => 2006-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 52023
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20070207949.pdf
[firstpage_image] =>[orig_patent_app_number] => 11635470
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/635470 | Medicaments and methods combining a HCV protease inhibitor and an AKR competitor | Dec 6, 2006 | Abandoned |
Array
(
[id] => 4478123
[patent_doc_number] => 07906617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-15
[patent_title] => 'Polyethylene binding peptides and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/607672
[patent_app_country] => US
[patent_app_date] => 2006-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 15
[patent_no_of_words] => 17960
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/906/07906617.pdf
[firstpage_image] =>[orig_patent_app_number] => 11607672
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/607672 | Polyethylene binding peptides and methods of use | Nov 30, 2006 | Issued |
Array
(
[id] => 4823046
[patent_doc_number] => 20080227717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Potent compstatin analogs'
[patent_app_type] => utility
[patent_app_number] => 11/605182
[patent_app_country] => US
[patent_app_date] => 2006-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14141
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227717.pdf
[firstpage_image] =>[orig_patent_app_number] => 11605182
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/605182 | Potent compstatin analogs | Nov 27, 2006 | Issued |